Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

被引:74
作者
White, A. Clinton, Jr. [1 ]
Coyle, Christina M. [2 ]
Rajshekhar, Vedantam [3 ]
Singh, Gagandeep [4 ]
Hauser, W. Allen [5 ]
Mohanty, Aaron [1 ]
Garcia, Hector H. [6 ,7 ]
Nash, Theodore E. [8 ]
机构
[1] Univ Texas Med Branch, Galveston, TX 77555 USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India
[4] Dayanand Med Coll, Ludhiana, Punjab, India
[5] Columbia Univ, New York, NY USA
[6] Inst Nacl Ciencias Neurol, Lima, Peru
[7] Univ Peruana Cayetano Heredia, Lima, Peru
[8] NIH, Bldg 10, Bethesda, MD 20892 USA
关键词
LINKED IMMUNOELECTROTRANSFER BLOT; SOLITARY CYSTICERCUS GRANULOMA; ENDOSCOPIC 3RD VENTRICULOSTOMY; TERM ANTIEPILEPTIC TREATMENT; ENHANCING CT LESION; DOUBLE-BLIND; CEREBRAL CYSTICERCOSIS; ALBENDAZOLE THERAPY; FOLLOW-UP; HYDROCEPHALUS SECONDARY;
D O I
10.4269/ajtmh.18-88751
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Guidelines for the clinical management of patients with neurocysticercosis (NCC) were prepared by a panel of the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). The guidelines are intended for infectious disease specialists, neurologists, neurological surgeons, internists, pediatricians, and family practitioners. These guidelines present our approaches to the diagnosis and management of patients with the different forms of NCC, including viable parenchymal NCC (VPN), single enhancing lesions (SEL), calcified parenchymal NCC (CPN), ventricular NCC (IVN), and subarachnoid NCC (SAN). Our recommendations are based on the best evidence available. Because of the complex variations in clinical manifestations and the limitations of the literature, many of the recommendations are based on observational studies, anecdotal data, or expert opinion rather than randomized clinical trials. The approaches we describe are intended to be both applicable and feasible in the United States and Canada (for simplicity, referred to here as North America). The recommendations may not apply for settings where resource constraints may limit their applicability. The executive summary in the following paragraphs lists the recommendations for the diagnosis and clinical management of NCC. A detailed description of the methods, background, and evidence summaries that support each of the recommendations can be found online in the full text of the guidelines. A criterion for grading evidence is presented in Figure 1.1 Note that diagnosis and management of patients with NCC can be challenging even with expert guidelines. Because of this complexity, clinicians with little experience with this disease should have a low threshold for consultation with an expert in the disease. © 2018 by The American Society of Tropical Medicine and Hygiene.
引用
收藏
页码:945 / 966
页数:22
相关论文
共 153 条
  • [31] Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: A prospective study using serial magnetization transfer imaging
    de Souza, Aaron
    Nalini, Atchayaram
    Kovoor, Jerry M. E.
    Yeshraj, Gangappa
    Siddalingaiah, Hanumanthaiah S.
    Thennarasu, Kandavel
    [J]. EPILEPSIA, 2011, 52 (10) : 1918 - 1927
  • [32] CEREBRAL CYSTICERCOSIS TREATED BIPHASICALLY WITH DEXAMETHASONE AND PRAZIQUANTEL
    DEGHETALDI, LD
    NORMAN, RM
    DOUVILLE, AW
    [J]. ANNALS OF INTERNAL MEDICINE, 1983, 99 (02) : 179 - 181
  • [33] Del Brutto O H., 1998, Neurocysticercosis: A clinical handbook
  • [34] Proposed diagnostic criteria for neurocysticercosis
    Del Brutto, OH
    Rajshekhar, V
    White, AC
    Tsang, VCW
    Nash, TE
    Takayanagui, OM
    Schantz, PM
    Evans, CAW
    Flisser, A
    Correa, D
    Botero, D
    Allan, JC
    Sarti, E
    Gonzalez, AE
    Gilman, RH
    García, HH
    [J]. NEUROLOGY, 2001, 57 (02) : 177 - 183
  • [35] Meta-analysis:: Cysticidal drugs for neurocysticercosis:: Albendazole and praziquantel
    Del Brutto, Oscar H.
    Roos, Karen L.
    Coffey, Christopher S.
    Garcia, Hector H.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) : 43 - 51
  • [36] Del Brutto Oscar H, 2014, Neurohospitalist, V4, P205, DOI [10.1016/B978-0-7020-4088-7.00097-3, 10.1177/1941874414533351]
  • [37] Short Report: The Importance of Neurocysticercosis in Stroke in Rural Areas of a Developing Latin American Country
    Del Brutto, Oscar H.
    Lama, Julio
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (02) : 374 - 375
  • [38] Intramedullary cysticercosis of the spinal cord: A review of patients evaluated with MRI
    Del Brutto, Oscar H.
    Garcia, Hector H.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 331 (1-2) : 114 - 117
  • [39] Diagnostic criteria for neurocysticercosis, revisited
    Del Brutto, Oscar H.
    [J]. PATHOGENS AND GLOBAL HEALTH, 2012, 106 (05) : 299 - 304
  • [40] DELATOUR P, 1981, ANN RECH VET, V12, P159